Siamak Davani

Dr. Siamak Davani

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2008 in Molecular Diagnosis & Therapy
Verified
Journal Article
Closed access
PDF file
YLYongfang Li
Yongfang Li
JKJean-Pierre Kantelip
Jean-Pierre Kantelip
PSPauline Gerritsen-Van Schieveen
Pauline Gerritsen-Van Schieveen
SDSiamak Davani
Siamak Davani

1 May 2019 in Journal of Insect Science
Verified
Journal Article
Open access
PDF file
VRVahideh Rabani
Vahideh Rabani
HCHamed Cheatsazan
Hamed Cheatsazan
SDSiamak Davani
Siamak Davani
Farming insects has recently emerged as a new source of protein and lipid production. To date, research has mostly focused on food applications of insects. Focusing on nonfood potential of oil and proteins of insects, high-throughput studies of insect lipids and proteins are needed. We performed proteomics and lipidomics investigation on black soldier fly (Hermitia illucens) and blow fly (Lucilia sericata) larvae to investigate new potential and applications. We used mass spectrometry for proteomics and lipidomics analysis of control and treated larvae. Treatment was performed by incubation with a biological decomposer. We provide the list of all fatty acids with their concentration in control and treated larvae. This result showed high levels of lauric acid in black soldier fly, which could even increase after biological decomposition. Proteomics analysis showed the presence of proteins like collagen of cosmetic interest, and proteins with antimicrobial properties such as phenoloxidases and enzymatic activities, such as amylase and trypsin. Insects harbor high potential for nonfood usage as additives, antimicrobial effects, and even pharmaceuticals and cosmetics. These data open avenues for future research in pharmacological and cosmetic approaches to find new molecules of interests.

1 November 2018 in Journal of Chromatography B
Verified
Journal Article
Closed access
JLJennifer Lagoutte-Renosi
Jennifer Lagoutte-Renosi
JPJulien Le Poupon
Julien Le Poupon
AGAlexandra Girard
Alexandra Girard
DMDamien Montange
Damien Montange
SDSiamak Davani
Siamak Davani

28 April 2016 in Platelets
Verified
Journal Article
Closed access
PDF file
VRVahideh Rabani
Vahideh Rabani
SDSiamak Davani
Siamak Davani
SGSégolène Gambert-Nicot
Ségolène Gambert-Nicot
NMNicolas Meneveau
Nicolas Meneveau
DMDamien Montange
Damien Montange
Lipid rafts play a pivotal role in physiological functions of platelets. Their isolation using nonionic mild detergents is considered as the gold standard method, but there is no consensual detergent for lipid raft studies. We aimed to investigate which detergent is the most suitable for lipid raft isolation from platelet membrane, based on lipidomics and proteomics analysis. Platelets were obtained from healthy donors. Twelve sucrose fractions were extracted by three different detergents, namely Brij 35, Lubrol WX, and Triton X100, at 0.05% and 1%. After lipidomics analysis and determination of fractions enriched in cholesterol (Ch) and sphingomyelin (SM), proteomics analysis was performed. Lipid rafts were mainly observed in 1–4 fractions, and non-rafts were distributed on 5–12 fractions. Considering the concentration of Ch and SM, Lubrol WX 1% and Triton X100 1% were more suitable detergents as they were able to isolate lipid raft fractions that were more enriched than non-raft fractions. By proteomics analysis, overall, 822 proteins were identified in platelet membrane. Lipid raft fractions isolated with Lubrol WX 0.05% and Triton X100 1% contained mainly plasma membrane proteins. However, only Lubrol WX 0.05 and 1% and Triton X100 1% were able to extract non-denaturing proteins with more than 10 transmembrane domains. Our results suggest that Triton X100 1% is the most suitable detergent for global lipid and protein studies on platelet plasma membrane. However, the detergent should be adapted if investigation of an association between specific proteins and lipid rafts is planned.

Verified
Journal Article
Open access
PDF file
JLJennifer Lagoutte-Renosi
Jennifer Lagoutte-Renosi
FAFlorentin Allemand
Florentin Allemand
CRChristophe Ramseyer
Christophe Ramseyer
VRVahideh RABANI
Vahideh RABANI
SDSiamak Davani
Siamak Davani
Lipids contained in the plasma membrane of platelets play an important role in platelet function. Modifications in the lipid composition can fluidify or rigidify the environment around embedded receptors, in order to facilitate the access of the receptor by the drug. However, data concerning the lipid composition of platelet plasma membrane need to be updated. In addition, data on the impact of drugs on plasma membrane composition, in particular antiplatelet agents, remain sparse. After isolation of platelet plasma membrane, we assessed, using lipidomics, the effect of ticagrelor, a P2Y12 antagonist, and its active metabolite on the lipid composition of these plasma membranes. We describe the exact lipid composition of plasma membrane, including all sub-species. Ticagrelor and its active metabolite significantly increased cholesterol and phosphatidylcholine ether with short saturated acyl chains 16:0/16:0, and decreased phosphatidylcholine, suggesting overall rigidification of the membrane. Furthermore, ticagrelor and its active metabolite decreased some arachidonylated plasmalogens, suggesting a decrease in availability of arachidonic acid from the membrane phospholipids for synthesis of biologically active mediators. To conclude, ticagrelor and its active metabolite seem to influence the lipid environment of receptors embedded in the lipid bilayer and modify the behavior of the plasma membrane.

1 July 2011 in European Journal of Cardio-Thoracic Surgery
Verified
Journal Article
Open access
PDF file
EPEric Parietti
Eric Parietti
JPJean-René Pallandre
Jean-René Pallandre
FDFrederic Deschaseaux
Frederic Deschaseaux
BABertrand Aupècle
Bertrand Aupècle
CDCamille Durst
Camille Durst
SDSiamak Davani
Siamak Davani
Objective: Circulating endothelial progenitor cells (EPCs) are a specialized subset of stem/progenitor cells found in bone marrow. They participate in neo-vascularization of injured vessels and predict cardiovascular outcome in patient at risk. Several factors influence their migration and proliferation, among which is the widely studied stromal-derived factor-1α (SDF-1α). In cardiovascular disease, regarding thoracic aortic aneurysms (TAAs), few studies have investigated the levels of EPC and SDF-1α. As rupture, acute dissection and hematoma are acute complications of idiopathic ascending thoracic aortic aneurysm (iATAA) that increase with the size of aneurysm, we aimed to evaluate a potential relationship between circulating EPC and SDF-1α and iATAA size. Methods: The aneurysm size of 27 consecutive patients suffering from iATAA and scheduled for surgery was assessed by computed tomography scan. In all patients, we measured levels of circulating EPCs by flow cytometer, and plasma levels of SDF-1α the day before surgery. Results: The median aneurysm size was 54 mm (interquartile range (IQR): 50.0–58.8]. The EPC levels of CD34+/CD144+/CD14− and CD34+/VEGF−R2+/CD14− were inversely correlated to aneurysm diameter (p = 0.038, r = −0.424 and p = 0.0046, r = −0.65, respectively) before surgery. Conversely, plasma levels of SDF-1α were positively correlated to aneurysm size (p = 0.042; r = 0.47). Conclusions: Our findings indicate that EPC levels may be useful for monitoring ascending aorta aneurysms and that SDF-1α could be a biomarker of iATAA expansion.